Horizon Kinetics Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
353,471
+23,901
| +7% | +$861K | 0.15% | 50 |
|
|
2025
Q1 | $10.3M | Buy |
329,570
+10,394
| +3% | +$324K | 0.12% | 54 |
|
|
2024
Q4 | $8.14M | Buy |
319,176
+90,380
| +40% | +$2.31M | 0.1% | 57 |
|
|
2024
Q3 | $6.47M | Buy |
228,796
+12
| +0% | +$339 | 0.1% | 63 |
|
|
2024
Q2 | $6.03M | Buy |
228,784
+28,496
| +14% | +$751K | 0.11% | 62 |
|
|
2024
Q1 | $6.08M | Sell |
200,288
-16,402
| -8% | -$498K | 0.12% | 57 |
|
|
2023
Q4 | $6.09M | Sell |
216,690
-70,565
| -25% | -$1.98M | 0.13% | 56 |
|
|
2023
Q3 | $7.8M | Sell |
287,255
-46,414
| -14% | -$1.26M | 0.15% | 53 |
|
|
2023
Q2 | $10.3M | Sell |
333,669
-39,451
| -11% | -$1.21M | 0.22% | 52 |
|
|
2023
Q1 | $13.4M | Sell |
373,120
-26,760
| -7% | -$964K | 0.26% | 44 |
|
|
2022
Q4 | $15.8M | Sell |
399,880
-8,666
| -2% | -$342K | 0.26% | 40 |
|
|
2022
Q3 | $16.4M | Sell |
408,546
-45,010
| -10% | -$1.81M | 0.33% | 37 |
|
|
2022
Q2 | $19.1M | Buy |
453,556
+62,638
| +16% | +$2.63M | 0.4% | 38 |
|
|
2022
Q1 | $15.2M | Buy |
390,918
+108,381
| +38% | +$4.22M | 0.31% | 46 |
|
|
2021
Q4 | $11.3M | Buy |
282,537
+42,209
| +18% | +$1.68M | 0.25% | 52 |
|
|
2021
Q3 | $8.69M | Buy |
240,328
+27,071
| +13% | +$978K | 0.2% | 54 |
|
|
2021
Q2 | $8.74M | Buy |
213,257
+163,492
| +329% | +$6.7M | 0.18% | 57 |
|
|
2021
Q1 | $2.17M | Buy |
+49,765
| New | +$2.17M | 0.05% | 110 |
|